AUG 22 2016, 5:01 PM ET

Senators Demand Mylan Justify EpiPen Price Hikes

by BEN POPKEN

U.S. Senators are scrutinizing the rising price of EpiPens following a public outcry over the 400 percent price hike since 2008.

On Monday, Senator Charles Grassley of Iowa, chairman of the Senate Judiciary Committee, sent a letter to Heather Bresch, chief executive officer of Mylan, the maker of EpiPens. The letter, which cited earlier NBC News reporting, said he was "concerned that the substantial price increase could limit access to a much-needed medication" and requested additional information on the price increases.

Separately, Connecticut Senator Richard Blumenthal urged Mylan to reduce the price of EpiPens.

"I demand that Mylan take immediate action to lower the price of EpiPen's for all Americans that rely on this product for their health and safety," he wrote in a letter to Bresch, citing hearing from dozens of concerned families, school nurses and first responders.

They join Senator Amy Klobuchar of Minnesota, the top Democrat on the Judiciary committee's antitrust subcommittee, ...

[font size=1]-snip-[/font]